muscular dystrophy Bionano Genomics Launches CLIA-Certified Laboratory, First OGM-Based Test Bionano Laboratories will offer services to clinical customers seeking to implement OGM for routine diagnostic use. PerkinElmer Newborn Screening Assay Receives CE-IVD Mark The company's Eonis assay, which leverages RT-PCR technology, can be used to simultaneously tests for SMA, SCID, and XLA in newborns. CureDuchenne, UC Irvine, RUCDR Partner on Muscular Dystrophy Biobank The project will provide approved researchers with access to samples and deidentified data collected from volunteer patients with Duchenne muscular dystrophy. FDA Awards $2.4M to Vanderbilt Researcher for Duchenne Muscular Dystrophy Biomarker Study Hallmarks of the genetic disease, which can result in life-threatening cardiac complications, include progressive weakness and loss of heart muscle. Sanofi Genzyme, PerkinElmer Launch Free Dx Program for Patients With Lysosomal Storage Disorders The Lantern Project will screen for patients who may be suffering from Gaucher disease, Fabry disease, Pompe disease, MPS I, or ASMD, and offer confirmatory DNA testing. Apr 5, 2018 PerkinElmer To Provide Genetic Testing for Decode Duchenne Program Feb 1, 2018 New CRISPR-Based Myoediting Technique Simplifies Correction of DMD Mutations Dec 7, 2017 Researchers Use CRISPR to Epigenetically Alter Disease Phenotypes in Mice Oct 19, 2017 Genomic Vision, AmCare Genomics Ink Deal to Distribute Muscular Dystrophy Assay in China Apr 19, 2017 Tissue-Specific Transcriptome Used to Enhance Exome-, Genome-Based Dystrophy Diagnoses Feb 27, 2017 Gene-Editing Startup Exonics Therapeutics Receives $5M From CureDuchenne Ventures Jan 30, 2017 Parent Project Muscular Dystrophy Funds $250K CRISPR Grant for UT-Southwestern Jan 10, 2017 Absence of Nose, Adult Muscular Dystrophy Linked to Mutations in SMCHD1 Gene Oct 31, 2016 BioNano Genomics Pushing Genome Mapping Technology Into Human Research Market Premium Jul 26, 2016 UCLA Lands $2.2M CIRM Grant for CRISPR/Cas9 Gene Editing of DMD Mutations Jun 8, 2016 CRISPR Therapeutics Inks Licensing, Collaboration Deal With Anagenesis Biotechnologies Apr 20, 2016 Laminopathies Might Be Epigenetic Disorders, Researchers Suggest Mar 11, 2016 Emory Researcher Describes Search for Multigenic Forms of Muscular Dystrophy At ACMG Feb 4, 2016 Look for CRISPR/Cas9 to Treat Eye Diseases First, Scientists Say Jan 4, 2016 In Three Studies, CRISPR Effective in Improving Symptoms of Mice With Muscular Dystrophy Dec 11, 2015 Sick Kids Researchers Use CRISPR/Cas9 to Remove Duplications in Duchenne Muscular Dystrophy May 26, 2015 Researchers ID Nearly Four Dozen Proteins Whose Levels Vary in Duchenne Muscular Dystrophy Sep 30, 2014 Foundation Consortium Launches Program to Provide Free Genetic Testing for MD Patients Aug 14, 2014 Using Genome Editing Approach, Researchers Prevent Duchenne Muscular Dystrophy in Mouse Model Dec 4, 2013 Cellular Dynamics, Jain Foundation Ink Stem Cell Line Deal Load More Breaking News SARS-CoV-2 Mutational Signature Associated With Mutagenic Antiviral Drug Biocartis Restructures Balance Sheet as H1 2023 Revenues Rise 12 Percent Rare Kidney Cancer Genomic Analysis Reveals Potential Target, Suggests Treatment SEC Concludes CareDx Investigation, Recommends No Enforcement Action Streck Quality Controls for DiaSorin's Luminex Sepsis Tests Receive FDA Clearance The Scan Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants. Small Study of Gene Editing to Treat Sickle Cell Disease In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms. Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema. Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.